Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis.

Virchows Archiv : an international journal of pathology·2026
Same author

The Diagnostic Role of TFF1, TFF3, FOXA1, CA XII and TRPS1 in Serous Effusions.

Cytopathology : official journal of the British Society for Clinical Cytology·2025
Same author

Endometrial carcinomas with ambiguous histology often harbor TP53 mutations.

Virchows Archiv : an international journal of pathology·2024
Same author

Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations.

Virchows Archiv : an international journal of pathology·2024
Same author

Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance.

Clinical & experimental metastasis·2023
Same author

Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium.

Virchows Archiv : an international journal of pathology·2023
Same journal

Pleural Fluid Cytology Detects Small Cell Carcinoma Transformation in EGFR-Mutant Lung Adenocarcinoma: A Case Report.

Diagnostic cytopathology·2026
Same journal

Clinical and Cytopathological Significance of Intracytoplasmic Lumina and Immunohistochemical Mucin Expression in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder.

Diagnostic cytopathology·2026
Same journal

Pleural Effusion Cytology of Metastatic Sclerosing Epithelioid Fibrosarcoma.

Diagnostic cytopathology·2026
Same journal

Turnaround Time Trends in Cervical Cytology Screening in South Africa, 2005-2023.

Diagnostic cytopathology·2026
Same journal

Spontaneous Infarction of Benign Salivary Gland Tumors: A Series of 5 Cases.

Diagnostic cytopathology·2026
Same journal

Atypical Carcinoid Tumor Metastatic to the Parotid Gland: A Case Report and Review of the Literature.

Diagnostic cytopathology·2026
See all related articles

Related Experiment Video

Updated: Dec 29, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.5K

Molecular testing on serous effusions.

Ben Davidson1,2

  • 1Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

Diagnostic Cytopathology
|February 6, 2020
PubMed
Summary
This summary is machine-generated.

Cytopathology laboratories frequently analyze serous effusions. Advanced molecular testing of these effusions aids cancer diagnosis, prognosis, and targeted therapy selection.

Keywords:
diagnosismolecular testingpredictionprognosisserous effusions

More Related Videos

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.7K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

710

Related Experiment Videos

Last Updated: Dec 29, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.5K
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.7K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

710

Area of Science:

  • Cytopathology
  • Molecular Diagnostics
  • Oncology

Background:

  • Serous effusions are common in cytopathology.
  • Differential diagnosis often requires ancillary tests.
  • Immunohistochemistry is a primary diagnostic method.

Purpose of the Study:

  • To review recent advancements in the molecular analysis of serous effusions.
  • To highlight the role of molecular testing in cancer diagnosis and biology.
  • To discuss the utility of effusions in predicting targeted therapy response and prognosis.

Main Methods:

  • Review of recent studies on serous effusion analysis.
  • Analysis of various molecular markers including DNA, mRNA, noncoding RNA, and proteins.
  • Application of immunohistochemistry and other molecular techniques.

Main Results:

  • Serous effusions are valuable for molecular testing.
  • Molecular analysis aids in understanding tumor biology and progression.
  • Effusions provide critical data for predicting treatment outcomes.

Conclusions:

  • Molecular testing of serous effusions is increasingly important.
  • These analyses enhance diagnostic accuracy and patient stratification.
  • Serous effusions are key specimens for personalized cancer medicine.